Corrections:

Kun Zhang^1,*, Minhui Li^2,*, Houyi Huang^1,*, Linpeng Li^1,*, Jie Yang¹, Li Feng¹, Junjie Gou¹, Mengju Jiang¹, Liaotian Peng¹, Linyⁱ Chen¹, Ting Li¹, Ping Yang², Yuhan Yang¹, Yuanyuan Wang¹, Quekun Peng¹, Xiaozhen Dai¹ and Tao Zhang¹

¹School of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China
²School of Basic Medical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China
^*These authors contributed equally to this work

Published: November 23, 2021

Copyright: © 2021 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: In Figure 2E, the MRP2 blot panel was inadvertently duplicated in the BCRP blot panel. The corrected Figure 2E, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:115803–115816. DOI: https://doi.org/10.18632/oncotarget.23253

Figure 2: DVL increased expressions of P-gp, MRP2 and BCRP. (E) HCT-8/VCR cells transfected with shNC, shDVL, or shDVL plus pcDNA3.1-Flag-DVL for 72 h, were lysed to examine the protein levels of P-gp, MRP2 and BCRP, Flag-DVL1-3 and DVL1-3 using Western blotting. In each case, the blot was representative of immunoblots resulting from three separate experiments.